SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : NNVC - NanoViricides, Inc.
NNVC 1.160+2.7%Jan 16 9:30 AM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: mattstat who wrote (10068)4/17/2018 12:26:15 PM
From: BoredMember  Read Replies (1) of 12873
 
You are choosing to ignore that he was able secure multiple large rounds of financing, get the stock off the pinks and onto a real board, sign numerous agreements with top labs and professors, all experts in their fields and keep the stock from crashing to zero, while the FDA stalled and delayed and put unnecessary and burdensome requirements on them, likely at the request of BP who wants to keep Nanoviricide's revolutionary technology out of the market for fear it will destroy their strangle hold on the anti-viral treatments.

If he was compensated for all this, then in my opinion, that is fair. His work ethic and tireless working hours should be rewarded.

Those of us who understand what is happening now and what has happened in the past believe he was very effective and succeeded beyond expectation.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News